Blood safety and the choice of anti-hemophilic factor concentrate

Pediatr Blood Cancer. 2007 Jan;48(1):117. doi: 10.1002/pbc.21086.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Blood Donors
  • Blood-Borne Pathogens*
  • Factor IX / adverse effects
  • Factor IX / therapeutic use
  • Factor VIII / adverse effects
  • Factor VIII / therapeutic use
  • Hemophilia A / therapy
  • Humans
  • Risk Factors
  • Safety*
  • Virus Diseases / prevention & control*
  • Virus Inactivation*

Substances

  • Factor VIII
  • Factor IX